Compass Therapeutics, Inc.
CMPX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001738021
In the last 90 days, Compass Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 215 institutions reported holding it in 13F filings for Q2 2026, worth $363.4M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Compass Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- −3 vs. Q4 2021
- Shares held
- 62.4M
- −1.19M (−1.9%) vs. Q4 2021
- Total value
- $85.4M
- −$116.3M (−57.7%) vs. Q4 2021
- New holders
- 7
- 6 more added
- Sold out
- 10
- 5 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CMPX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 215 | $363.4M |
| Q1 2026 | 201 | $921.3M |
| Q4 2025 | 173 | $881.5M |
| Q3 2025 | 125 | $535.7M |
| Q2 2025 | 103 | $281.9M |
| Q1 2025 | 108 | $206.1M |
| Q4 2024 | 92 | $147.0M |
| Q3 2024 | 79 | $169.7M |
| Q2 2024 | 82 | $93.5M |
| Q1 2024 | 78 | $187.9M |
| Q4 2023 | 77 | $134.8M |
| Q3 2023 | 76 | $176.7M |
| Q2 2023 | 73 | $287.7M |
| Q1 2023 | 73 | $285.1M |
| Q4 2022 | 55 | $401.4M |
| Q3 2022 | 38 | $153.7M |
| Q2 2022 | 34 | $163.9M |
| Q1 2022 | 34 | $85.4M |
| Q4 2021 | 37 | $201.6M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Compass Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 21,642,975 | $29.7M | 0.48% | 00.0% | Unchanged |
| FMR LLC | 6,872,414 | $9.42M | 0.00% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 5,328,088 | $7.30M | 0.18% | 00.0% | Unchanged |
| Foresite Capital Management V, LLC | 4,400,000 | $6.03M | 2.46% | 00.0% | Unchanged |
| Consonance Capital Management LP | 3,500,000 | $4.74M | 8.05% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 3,193,294 | $4.33M | 0.00% | +1,720,683+116.8% | Added |
| CHI Advisors LLC | 2,829,712 | $3.88M | 1.65% | −193,980−6.4% | Reduced |
| Adage Capital Partners GP, L.L.C. | 2,277,000 | $3.12M | 0.01% | +877,000+62.6% | Added |
| Vivo Capital, LLC | 2,000,000 | $2.74M | 0.19% | 00.0% | Unchanged |
| Avidity Partners Management LP | 2,000,000 | $2.74M | 0.06% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,572,882 | $2.15M | 0.00% | 00.0% | Unchanged |
| Blackstone Group Inc. | 1,505,738 | $2.06M | 0.01% | 00.0% | Unchanged |
| Monashee Investment Management LLC | 1,270,211 | $1.74M | 0.50% | −729,789−36.5% | Reduced |
| Foresite Capital Opportunity Management V, LLC | 1,100,000 | $1.51M | 2.11% | 00.0% | Unchanged |
| Fred Alger Management, LLC | 608,536 | $834.0K | 0.00% | −210,209−25.7% | Reduced |
| Farallon Capital Management, L.L.C. | 582,750 | $798.0K | 0.00% | −417,250−41.7% | Reduced |
| Ra Capital Management, L.P. | 532,958 | $730.0K | 0.02% | −1,316,560−71.2% | Reduced |
| CM Management, LLC | 300,000 | $411.0K | 0.35% | +300,000 | New |
| DAFNA Capital Management LLC | 196,091 | $269.0K | 0.07% | 00.0% | Unchanged |
| Alphabet Inc. | 192,794 | $264.0K | 0.01% | 00.0% | Unchanged |
| Salem Investment Counselors Inc | 100,000 | $137.0K | 0.01% | 00.0% | Unchanged |
| LMR Partners LLP | 100,000 | $137.0K | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 74,171 | $100.0K | 0.03% | +4,171+6.0% | Added |
| Qube Research & Technologies Ltd | 52,842 | $72.0K | 0.00% | +23,789+81.9% | Added |
| Millennium Management LLC | 38,545 | $53.0K | 0.00% | +27,388+245.5% | Added |
| Morgan Stanley | 26,977 | $37.0K | 0.00% | +9,504+54.4% | Added |
| Geode Capital Management, LLC | 24,857 | $34.0K | 0.00% | +24,857 | New |
| Mascoma Wealth Management LLC | 15,682 | $21.0K | 0.01% | 00.0% | Unchanged |
| B. Riley Wealth Management, Inc. | 14,918 | $20.0K | 0.00% | +14,918 | New |
| Renaissance Technologies LLC | 13,300 | $18.0K | 0.00% | +13,300 | New |
| UBS Group AG | 7,228 | $10.0K | 0.00% | 00.0% | Unchanged |
| Charter Oak Capital Management, LLC | 1,483 | $2.00K | 0.00% | +1,483 | New |
| Royal Bank of Canada | 783 | $1.00K | 0.00% | +783 | New |
| Bank of America Corp | 6 | $0 | 0.00% | +6 | New |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −700,000−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Octagon Capital Advisors LP | 0 | $0 | 0.00% | −240,000−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −37,834−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −33,573−100.0% | Sold out |
| New Capital Management LP | 0 | $0 | 0.00% | −24,243−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −23,749−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −18,880−100.0% | Sold out |
| Difesa Capital Management, LP | 0 | $0 | 0.00% | −10,337−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,205−100.0% | Sold out |